Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101

ABSTRACT: This is an open label, multicenter, phase 1/1b study to assess safety/tolerability and preliminary clinical activity of E7766 as a single agent administered intratumorally in participants with advanced solid tumors or lymphomas.

DISEASE(S): Melanoma,Colorectal Cancer,Advanced Solid Tumors,Breast Cancer,Lymphoma

PROVIDER: 2320470 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR